EXANE DERIVATIVES - GOLD STD VENTURES CORP ownership

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of GOLD STD VENTURES CORP
ValueSharesWeighting
Q3 2020$9,326,000
-5.0%
11,8930.0%0.00%0.0%
Q2 2020$9,820,000
+70.6%
11,8930.0%0.00%
+50.0%
Q1 2020$5,757,000
-35.1%
11,8930.0%0.00%0.0%
Q4 2019$8,875,000
-4.0%
11,8930.0%0.00%0.0%
Q3 2019$9,245,000
-25.7%
11,8930.0%0.00%0.0%
Q2 2019$12,445,000
+2.7%
11,8930.0%0.00%0.0%
Q1 2019$12,112,000
-18.8%
11,8930.0%0.00%
-33.3%
Q4 2018$14,919,000
-26.1%
11,8930.0%0.00%
-25.0%
Q3 2018$20,193,000
+24.3%
11,8930.0%0.00%
+33.3%
Q2 2018$16,247,00011,8930.00%
Other shareholders
GOLD STD VENTURES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
U S GLOBAL INVESTORS INC 1,150,000$1,438,0000.83%
SPROTT INC. 692,000$1,120,0000.31%
TOCQUEVILLE ASSET MANAGEMENT L.P. 9,513,500$11,916,0000.18%
INGALLS & SNYDER LLC 1,576,935$1,971,0000.10%
VAN ECK ASSOCIATES CORP 12,900,229$16,125,0000.08%
Camelot Portfolios, LLC 54,000$68,0000.03%
AGF INVESTMENTS INC. 1,030,200$1,290,0000.02%
CIBC Asset Management Inc 1,633,386$2,046,0000.02%
Kore Private Wealth LLC 39,275$49,0000.01%
MACKENZIE FINANCIAL CORP 1,288,000$1,610,0000.00%
View complete list of GOLD STD VENTURES CORP shareholders